Hemepath Flashcards
Acute Lymphoblastic Leukemia/Lymphoma
pre B cell ALL
Tdt + CD 10, 19,20 Favorable: t(12;21) Unfavorable: t (9;22) young (10)
Acute Lymphoblastic Leukemia/Lymphoma
pre T cell ALL
Mediastinal Mass(may cause dysphagia or vena cava syndrome) Associated with Down syndrome TdT+ CD2-8 Adolescent male, thymic involvement
Acute Myelogenous Leukemia
Older (esp>60) Myeloblasts >20% (don't forget about Myelodysplastic syndrome-nuclear irregularity, nuclear budding, multinucleation, separated nuclear lobes) MPO + Alpha naphthyl butyrate esterase CD 13, 33, 34, 117 Auer rods Favorable: t (8;21) t (15;17)=Acute promyelocytic leukemia--transposition of retinoic receptor gene-tx-all trans retinoic acid-crystal aggregates of MPO-auer rods-->DIC Inv(16) NPM Unfavorable T (11q23;v) FLT3
Chronic Leukemia:
Chronic lymphocytic leukemia/Small lymphocytic lymphoma (CLL/SLL)
>60y B-cell CD 5 (pan t-cell marker), CD 20, CD23 Smudge cells Hypoglobulinemia Autoimmune Hemolytic anemia CLL with increasing lymph node/spleen may develop to Richter syndrome: large B cell lymphoma
Chronic Leukemia:
Hairy cell Leukemia
Middle aged man with pancytopenia, splenomegaly of red pulp, and infections
- mature B cells w/ filamentous hair-like projections
- TRAP+
- Dry tap on BM aspiration
- Tx: cladribine (2-CDA)–>inhibits adenosine deaminase
- good prognosis
Chronic Leukemia
Adult T cell Leukemia/Lymphoma
tumor of CD4+ T cells due to HTLV-1 infection
- especially Japan
- punched out bone lesions, hypercalcemia, hepatosplenomegaly, LAD
- floret-like lymphocytes
- usually fatal
Hodgkin Lymphoma
bimodal age involvement low grade fever, night sweats, weight loss Classical Types 1. Lymphocyte rich (best prognosis) 2. Mixed cellularity 3. Lymphocyte depleted 4. Nodular sclerosis (CD 15, CD 30) 5. Nodular lymphocyte(CD 20, 45)
more RS–>worse prognosis
RS secrete cytokines–>stimulate reactive cells that make up majority of the tumor mass
Lymphocyte rich subtype
Reactive small lymphocytes predominate, few mononuclear or classic Reed-Sternberg cells
CD 15, 30
Mixed cellularity
Reed-Sternberg cells and variants on a mixed cellular background including eosinophils, plasma cells, T-lymphocytes, histiocytes
CD 15, 30
Lymphocyte depleted type
Paucity of lymphocytes and relative abundance of Reed-Sternberg cells
CD 15, 30
Nodular sclerosis
fibrous nodular pattern, lacunar cells
CD 15, 30
Nodular lymphocyte predominant subtype
nodularity with predominance of mature lymphocytes and popcorn cell or L & H variant of RS cells
CD 20, 45
Non-Hodgkin Lymphoma
Diffuse Large B cell Lymphoma
Large Cell
- most common non hodgkin lymphoma in adults
- usually older adults
- clinically aggressive
- Germinal center B cell or activated b cell(worse)
- 30% arise from follicular lymphoma t (14:18)
((14;18) or Bcl6) + Myc –>double hit
Non-Hodgkin Lymphoma
Burkitt Lymphoma
Medium Cell
t(8;14) –>over expression of c-myc–>increased proliferation
Sporadic: abdomen or pelvis
Endemic: Mandible, Africa, latent EBV
Rapid growth–>cell death–>macrophages “tingible bodies” clean up—>starry sky pattern
Non hodgkin Lymphoma
Follicular Lymphoma
Small Cell
40% of adult NHL
CD 20+ B cells
T(14;18) –>bcl2 over amplification–>anti apoptotic
waxing and waning painless lymphadenopathy
Treatment=rituximab *anti-CD20
-may transform to DLCL in 30% to 50% of cases (
Non hodgkin Lymphoma
Mantle Cell Lymphoma
Small Cell
4% of NHLs, older males
CD 5, CD20 B cells
t (11;14) –>over amplification of Cyclin D1 –>increased cel proliferation
Non hodgkin Lymphoma
Marginal Zone Lymphoma
Small Cell
associated with chronic inflammatory states
- hashimoto’s, sjogren’s, H pylori
- may regress w treatment (e.g. H pylori_)
Non Hodgkin Lymphoma
T-cell NOS
Lymphadenopathy, eosinophilia, pruritus, fever weight loss
-lack of specific histological features (wastebasket diagnosis)
CD3+ with loss of other pan T cell markers and genetic analysis
Plasma Cell Neoplasm
Multiple Myeloma
Chronic monoclonal plasma cell proliferation dependent on IL-6 CRAB hyperCalcemia Renal insufficiency Anemia Bone lytic lesions/Back pain
Increased risk of infection (#1 cause of death)
- Elevated serum protein b/c increased monoclonal IgG or IgA!!!
- Blood smear shows rouleaux formation
Diagnosis: Monoclonal M spike
Frequent cytogenetic abnormalities: FGFR3, Cyclin D1 and Cyclin D3 genes
Median age: 70 years
Bence jones proteinuria causing renal insufficiency
Light chain toxic to tubular epithelium. Amyloidosis of AL type
Plasma cell neoplasm
Monoclonal Gammopathy of Undetermined Significance (MGUS)
asymptomatic precursor to multiple myeloma
1-2% go on to develop MM each year
-most common plasma cell dyscrasia (3% persons older than 50 years old)
Plasma cell neoplasm
Waldenstrom macroglobulinemia
M spike=IgM hyperviscosity of blood--> hyperviscosity syndrome -headaches -blurred vision or visual loss -epistaxis -leg cramps -confusional episodes -NO lytic bone lesions
Chronic Myelogenous Leukemia
Peak age 45-85
t (9;22)–>bcr-abl
fusion with tyrosine kinase activity
increased neoplastic granulocytic precursors
-Mutation in pluripotent stem cell that can produce myeloid or lymphoid cells
Peripheral blood smear= increase neutrophils, metamyelocytes, basophils
Enlarging spleen suggests transition of ALL or AML
Tx=imatinib (inhibits bcr-abl tyrosine kinase)
Compare to leukemoid rxn
CML: immature and mature cells, white cell to red ratio off, marked splenomegaly
Leukemoid rxn: +leukocyte alkaline phosphatase, normal basophils, no t(9;22)
Polycythemia vera
JAK2 point mutation
- low EPO
- elevated hematocrit
- normal PaO2
- increase # of mast cells–>itching after showering
-hyperviscosity of blood–>claudication, ischemic digits, visual disturbances, digital extremity erythromelalgia (burning with discoloration), budd-chiari syndrome(abdominal pain, ascites, liver enlargement) , 70% hypertension
Tx=phlebotomy
Essential Thromboyctosis
JAK2, CALR, and MPL point mutations
-proliferation of predominatly megakaryocytic lineage cells
Symptoms: thrombosis/hemorrhage
No propensity to hyperuricemia/gout with ET because no nucleus present in platelets
Primary Myelofibrosis
Jak2, CALR, MPL point mutations
Initially hypercellular marrow
Later atypical megakaryocytic hyperplasia– fibroblast proliferation–>collagen deposition in BM–> necessity of extramedullary hematopoiesis–>dacrocytes (tear drop)
symptoms: severe fatigue, splenomegaly and hepatomegaly–>early satiety and abdominal discomfort, anemia
Tx: ruxolitinib (Jak2 inhibitor)